Larvol Delta - Bristol-Myers-Squibb-Announces-First-Presentation-of-Results-for-ZENBEXUS-iberdomide-in-Combination-with-Daratumumab-from-Phase-3-EXCALIBERRRMM-Trial-in-Relapsed-or-Refractory-Multiple-Myeloma

Zenbexus (iberdomide) - BMS

https://www.businesswire.com/news/home/20260924614211/en/Bristol-Myers-Squibb-Announces-First-Presentation-of-Results-for-ZENBEXUS-iberdomide-in-Combination-with-Daratumumab-from-Phase-3-EXCALIBER-RRMM-Trial-in-Relapsed-or-Refractory-Multiple-Myeloma

Sep 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next